| Daniel W Esper, MD | |
|
7 Southwoods Blvd, Capital Cardiology Associates, Pc, Albany, NY 12211-2526 | |
| (518) 292-6000 | |
| (518) 292-6050 |
| Full Name | Daniel W Esper |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 38 Years |
| Location | 7 Southwoods Blvd, Albany, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053305573 | NPI | - | NPPES |
| 060067449 | Other | NY | RR MEDICARE |
| 1007528 | Medicaid | VT | |
| 2011671 | Medicaid | MA | |
| 01359168 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 171697 (New York) | Primary |
| 207RI0011X | Internal Medicine - Interventional Cardiology | 171697 (New York) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Peter's Hospital | Albany, NY | Hospital |
| Albany Medical Center Hospital | Albany, NY | Hospital |
| Samaritan Hospital | Troy, NY | Hospital |
| Columbia Memorial Hospital | Hudson, NY | Hospital |
| Ellis Hospital | Schenectady, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Physician Associates Pllc | 1254228240 | 62 |
News Archive
A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).
While it is too early for physicians to start advising their male patients to take up the habit of regular coffee drinking, data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference revealed a strong inverse association between coffee consumption and the risk of lethal and advanced prostate cancers.
At a recent workout in Los Angeles, twenty shadow boxers throw their fists in the air, shouting and counting their punches.
SemBioSys Genetics Inc. today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of Botaneco Specialty Ingredients Inc. ("Botaneco") held by SemBioSys and Avrio Ventures Limited Partnership ("Avrio").
› Verified 8 days ago
| Entity Name | Capital Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518952332 PECOS PAC ID: 1254228240 Enrollment ID: O20040303000953 |
News Archive
A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).
While it is too early for physicians to start advising their male patients to take up the habit of regular coffee drinking, data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference revealed a strong inverse association between coffee consumption and the risk of lethal and advanced prostate cancers.
At a recent workout in Los Angeles, twenty shadow boxers throw their fists in the air, shouting and counting their punches.
SemBioSys Genetics Inc. today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of Botaneco Specialty Ingredients Inc. ("Botaneco") held by SemBioSys and Avrio Ventures Limited Partnership ("Avrio").
› Verified 8 days ago
| Entity Name | Capital Physician Associates Pllc |
|---|---|
| Entity Type | Part B Supplier - Intensive Cardiac Rehabilitation |
| Entity Identifiers | NPI Number: 1518952332 PECOS PAC ID: 1254228240 Enrollment ID: O20220512001887 |
News Archive
A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).
While it is too early for physicians to start advising their male patients to take up the habit of regular coffee drinking, data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference revealed a strong inverse association between coffee consumption and the risk of lethal and advanced prostate cancers.
At a recent workout in Los Angeles, twenty shadow boxers throw their fists in the air, shouting and counting their punches.
SemBioSys Genetics Inc. today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of Botaneco Specialty Ingredients Inc. ("Botaneco") held by SemBioSys and Avrio Ventures Limited Partnership ("Avrio").
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel W Esper, MD 7 Southwoods Blvd, Capital Cardiology Associates, Pc, Albany, NY 12211-2526 Ph: (518) 292-6000 | Daniel W Esper, MD 7 Southwoods Blvd, Capital Cardiology Associates, Pc, Albany, NY 12211-2526 Ph: (518) 292-6000 |
News Archive
A study recently published in the journal Matter has demonstrated the development and validation of a nanoparticle-based formulation, capable of completely inhibiting the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection blocking the interaction between viral spike protein and host cell angiotensin-converting enzyme 2 (ACE2).
While it is too early for physicians to start advising their male patients to take up the habit of regular coffee drinking, data presented at the American Association for Cancer Research Frontiers in Cancer Prevention Research Conference revealed a strong inverse association between coffee consumption and the risk of lethal and advanced prostate cancers.
At a recent workout in Los Angeles, twenty shadow boxers throw their fists in the air, shouting and counting their punches.
SemBioSys Genetics Inc. today announced that Advitech Inc. ("Advitech") has entered into a definitive agreement to acquire all of the issued and outstanding shares of Botaneco Specialty Ingredients Inc. ("Botaneco") held by SemBioSys and Avrio Ventures Limited Partnership ("Avrio").
› Verified 8 days ago
Arunima Rajbhandary, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 315 S Manning Blvd, Albany, NY 12208 Phone: 518-525-1550 | |
Dr. Rahul Ravilla, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 43 New Scotland Ave Ste 7, Albany, NY 12208 Phone: 518-262-6696 Fax: 518-262-2624 | |
Emmanuelle Cordero Torres, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 47 New Scotland Ave Dept Of Nephrology, Albany Medical Center, Albany, NY 12208 Phone: 518-262-5377 | |
Nancy Shrestha, MD Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 5 Palisades Dr Ste 200, Albany, NY 12205 Phone: 518-471-3636 Fax: 518-471-3668 | |
Stephen Hillinger, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 400 Patroon Creek Blvd, Suite 1, Albany, NY 12206 Phone: 518-489-0044 Fax: 518-489-3591 | |
Louis H Gold, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 5 Palisades Dr, Ste100, Albany, NY 12205 Phone: 518-438-4496 | |
Sean Joseph Sheehan, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1375 Washington Ave, Suite 101, Albany, NY 12206 Phone: 518-438-4483 Fax: 518-482-4201 |